200,000+ products from a single source!
sales@angenechem.com
CAS No: 130525-62-1 Catalog No: AG000UKC MDL No:
Title | Journal |
---|---|
Exploring the interactions of unsaturated glucuronides with influenza virus sialidase. | Journal of medicinal chemistry 20121025 |
The de-guanidinylated derivative of peramivir remains a potent inhibitor of influenza neuraminidase. | Bioorganic & medicinal chemistry letters 20111201 |
Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses. | Bioorganic & medicinal chemistry 20100601 |
Reduced sensitivity of influenza A (H5N1) to oseltamivir. | Emerging infectious diseases 20070901 |
Analysis of inhibitor binding in influenza virus neuraminidase. | Protein science : a publication of the Protein Society 20010401 |
The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA. | Journal of virology 20001201 |
A novel approach to antiviral therapy for influenza. | The Journal of antimicrobial chemotherapy 19991101 |
Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B. | Journal of medicinal chemistry 19980312 |
A study of the active site of influenza virus sialidase: an approach to the rational design of novel anti-influenza drugs. | Journal of medicinal chemistry 19960119 |
4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. | Antimicrobial agents and chemotherapy 19930701 |
Rational design of potent sialidase-based inhibitors of influenza virus replication. | Nature 19930603 |
© 2019 Angene International Limited. All rights Reserved.